Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 67296-2286

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 67296-2286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (3c3a2ddd 8711 416c 813e 63c64f579ac2 01)

A forest plot chart showing hazard and odds ratios from various epidemiological studies including prospective cohort, retrospective cohort, case-control, and studies on non-fetal idiopathic cases. The x-axis is logarithmic, ranging approximately from 0.1 to 10, with a vertical line at 1 indicating no effect. Data points for each study are displayed with confidence intervals represented as horizontal lines.*

FDA Label Image

Figure 2 (3c3a2ddd 8711 416c 813e 63c64f579ac2 02)

A horizontal bar graph comparing blood clot incidence among different groups of women. The groups include Non-Pregnant Non-COC users, COC users, Pregnancy, and Postpartum (12 weeks only). The x-axis shows the number of women with a blood clot per 10,000 woman-years (WY) ranging from 0 to 70, with Postpartum showing the highest range (40 to 65) and Non-Pregnant Non-COC users the lowest (1 to 5). The graph includes a note about pregnancy data duration and rate assumptions.*

FDA Label Image

Figure 3: Relative Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (3c3a2ddd 8711 416c 813e 63c64f579ac2 03)

A forest plot chart comparing risk effect estimates (odds ratios, relative risks, and hazard ratios) for various studies on combined oral contraceptive (COC) use labeled as 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-use.' The chart lists studies with their authors and dates on the left and numerical effect estimates with 95% confidence intervals represented by horizontal lines and dots on the right. The x-axis is labeled 'Effect Estimate' ranging approximately from -1.5 to 2.0. Notes below clarify abbreviations for RR, OR, HR, and definitions of 'ever COC' and 'never COC' users.*

FDA Label Image

Structure Formula (3c3a2ddd 8711 416c 813e 63c64f579ac2 04)

Chemical structure diagrams of Drospirenone and Ethinyl estradiol, the active ingredients in the prescription drug kit labeled by Redpharm Drug. The image shows the molecular structures of both compounds side by side with their chemical bonds and groups clearly depicted.*

FDA Label Image

Image (3c3a2ddd 8711 416c 813e 63c64f579ac2 05)

Text stating that LUPIN and the related symbol are registered trademarks of Lupin Pharmaceuticals, Inc. This is a trademark notice typically found in drug labeling or informational documents.*

FDA Label Image

Image (3c3a2ddd 8711 416c 813e 63c64f579ac2 06)

An effectiveness chart illustrating various birth control methods and their relative pregnancy rates per 100 women per year. Methods with fewer pregnancies include implants, injections, intrauterine devices, and sterilization. Moderate effectiveness methods listed are birth control pills, skin patch, and vaginal ring with hormones. Less effective methods include condoms and diaphragm, while no sex during fertile days, spermicide, and withdrawal indicate higher pregnancy rates. No birth control shows the highest pregnancy occurrence.*

FDA Label Image

Image (3c3a2ddd 8711 416c 813e 63c64f579ac2 07)

Illustrative dosing schedule diagram for a 28-day pill kit, organized by day of the week (Sunday through Saturday) and divided into four weeks. The diagram uses arrows to guide daily pill intake sequence and includes a monthly reminder to perform a breast self-exam. This figure likely accompanies a DROSPIRENONE AND ETHINYL ESTRADIOL oral contraceptive kit to aid user adherence.*

FDA Label Image

Figure (3c3a2ddd 8711 416c 813e 63c64f579ac2 08)

A horizontal bar chart illustrating the number of women with a blood clot per 10,000 women years (WY) across four categories: Non-Pregnant Non-COC users (range 1 to 5), COC users (range 3 to 9), Pregnant women (range 5 to 20), and Postpartum women within 12 weeks (range 40 to 65). Additional note explains pregnancy data is based on actual duration used in reference studies, with a model assumption of nine months pregnancy duration corresponding to a rate of 7 to 27 per 10,000 WY.*

FDA Label Image

Image (3c3a2ddd 8711 416c 813e 63c64f579ac2 09)

FDA Label Image

Wallet, Carton (3c3a2ddd 8711 416c 813e 63c64f579ac2 10)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets USP 3 mg/0.03 mg. The label includes storage instructions, manufacturer Lupin Pharmaceuticals, Inc., and a barcode. The kit also includes a forming foil/PVC blister pack layout indicating days of the week and four weeks of tablet placement for a monthly regimen.*

FDA Label Image

Pouch (3c3a2ddd 8711 416c 813e 63c64f579ac2 11)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.03 mg, in a kit form. The label shows one blister of 28 tablets. The label includes the Lupin logo and states the product is Rx only. There is a warning that the product is intended to prevent pregnancy and does not protect against HIV or other sexually transmitted diseases.*

FDA Label Image

Carton (3c3a2ddd 8711 416c 813e 63c64f579ac2 12)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.03 mg, in a kit form. The label shows this is prescription only (Rx only) and contains 3 blisters of 28 tablets each. Distributed by Lupin Pharmaceuticals, Inc. and manufactured by Lupin Limited in India. The label includes barcodes, dosage details, and a warning that the product is intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.